Systemic Therapy for Melanoma
American Society of Clinical OncologyPublished: September 6, 2023
- Key Points
- Treatment
- Neoadjuvant Systemic Therapy
- Cutaneous Melanoma Eligible for Resection
- Adjuvant Systemic Therapy
- Resected (Stage II, III, IV) Cutaneous Melanoma
- Systemic Therapy Options
- Unresectable/Metastatic Cutaneous Melanoma
- Non-Cutaneous Melanoma (Stage II or Greater)
- Neoadjuvant Systemic Therapy
- Tables
- Reasonable Dose and Schedule Details for Recommended Regimens — Neoadjuvant and Adjuvant Therapy
- Reasonable Dose and Schedule Details for Recommended Regimens — Unresectable and/or Metastatic Disease
- Figure
- Systemic Therapy for Melanoma
Also Found In
You rely on Guideline Central for transparency
Guideline Central and select third party use “cookies” on this website to enhance the user experience.
This technology helps us gather statistical and analytical information to optimize the relevant content for you.
The user also has the option to opt-out which may have an effect on the browsing experience.